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LETTER TO THE EDITOR
Variation in Cardiovascular Magnetic Resonance
Myocardial Contouring: Insights From an International
Survey
William E. Moody,1,2,3 Lucy E. Hudsmith,3 Ben Holloway,4
Thomas A. Treibel,5 Rhodri Davies,5 Rebecca Kozor,6
Christian Hamilton-Craig,7 Nicola C. Edwards,8
William M. Bradlow,3 James C. Moon,5 and Richard P. Steeds,2,3
On behalf of the British Society of Cardiovascular Magnetic
Resonance and the Australia and New Zealand Working Group
for Cardiovascular Magnetic Resonance
To the Editor:
Cardiac magnetic resonance imaging (MRI) is the reference standard
for accurately quantifying cardiac volumes, mass, and systolic function.
Standardized methodology published almost a decade ago recom-
mended short-axis steady-state free precession (SSFP) cine imaging,1
which remains the workhorse of most protocols today. Although the
Society of Cardiovascular Magnetic Resonance (SCMR) recently
acknowledged "moderate variability" in normal ranges, depending on
the method of quantiﬁcation,2 use of a single normal reference range
has never been stipulated, rather that any reference range should be
aligned with the reporting technique. In the earlier datasets derived
from SSFP short-axis imaging, manual contouring was used to delin-
eate the endocardial border from the ventricular blood pool, resulting
in an image resembling the "fjords of Norway," where papillary mus-
cles and trabeculae were included in the left ventricular (LV) mass.
A pooled meta-analysis provided the largest reference range dataset
(n = 288) using this "detailed" contouring technique.3 In contrast, in
2017 the UK Biobank project published normal reference ranges
using ellipsoid "smoothed" contours of the compacted endocardial
border, including 800 healthy subjects.4 It is unclear which of these
methodologies are being used in real-life clinical practice. To address
this issue, we conducted an international survey examining contempo-
raneous cardiac MRI reporting practice.
An electronic survey was sent to all members of the British Society
of Cardiovascular Magnetic Resonance (BSCMR) and the Australia and
New Zealand Working Group for Cardiovascular Magnetic Resonance
(ANZCMR). Its content was developed with reference to the SCMR
guidelines for reporting cardiac MRI, and by consensus through the
BSCMR and ANZCMR. Questions focused on the precise methodology
and reference ranges used for assessing mass, volumes, and function.
Fifty-ﬁve international centers participated in the study. Of the
68 adult UK centers identiﬁed, 45 (66%) returned the questionnaire;
over half (58%) were from tertiary hospitals. Cardiologists completed the
majority of questionnaires (82%). In Australia and New Zealand, 10 of
the 12 major academic cardiac MRI centers (83%) responded.
Numerous different software vendors were used for image inter-
pretation and postprocessing, with wide variation in the choice of normal
reference ranges between centers (Table 1). For routine clinical reporting,
more readers used detailed (56%) than smoothed (44%) endocardial
contouring. Papillary muscles and trabeculations were included in the
LV blood volume in 46%. The majority of respondents (77%) used
normal reference ranges derived from methods that included papillary
muscles and trabeculations as LV mass, but only 32% of observers drew
them as such—a major inconsistency. Mitral valve plane tracking soft-
ware was used by only 26%, while 6% did not report LV mass at all.
For the right ventricle, most centers (64%) used detailed endocardial
contouring, with a smaller proportion using smoothed contours (27%)
or merely visual assessment (11%). Most centers (66%) did not run a
speciﬁc training program on volumetric analysis.
This survey has revealed wide variation between international
centers in the contouring methods used to quantitate cardiac vol-
umes, mass, and function. According to SCMR recommendations,
the choice of reference ranges and clinical reporting technique should
match, although these data highlight discordance. This may relate to
TABLE 1. Postprocessing Software, Reference Range,
and Myocardial Contouring Technique (n = 65)
Postprocessing softwarea %
Circle Cvi42 56
CMRtools 5
Philips 13
Siemens Argus / Syngovia 36
Othersb 19
Normal reference range
Maceira et al7 39
Petersen et al4 23
Kawel-Boehm et al3 17
Hudsmith et al5 7
Alfakih et al6 5
In-house reference range/Other 9
Left Ventricular Myocardial Contours
Detailed 56
Smoothed 44
Data are percentages taken from a total of 65 respondents from
55 international cardiac MRI centers.
aNot mutually exclusive.
bIncludes QMass Medis Medical, GE Healthcare (Suiteheart),
CIM (University of Auckland).
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TABLE 2. Comparison of Volumetric Analysis in 20 Patients With Hypertrophic Cardiomyopathy Using Detailed
vs. Smoothed Contouring Methods
Parameter
Detailed
contouring
Smoothed
contouring
Absolute
difference
Mean relative
difference P
LVEDV (mL) 108  33 131  35 +23  10 +21% <0.0001
LVESV (mL) 24  13 40  17 +16  6 +67% <0.01
LVSV (mL) 84  25 91  23 +7  8 +8% <0.001
LVEF (%) 78  10 70  9 −8  4 −10% <0.0001
LV mass (g) 178  51 148  40 −30  14 −17% <0.0001
LV mass index
(g/m2)
90  33 71  17 −20  26 −22% <0.01
LV, left ventricle; EDV, end-diastolic volume; ESV, end-systolic volume; SV, stroke volume; EF, ejection fraction.
Data are presented as mean  standard deviation. Comparisons were made with a two-tailed, paired Student’s t-test. P < 0.05 was
considered signiﬁcant.
FIGURE 1: Example of detailed and smoothed left ventricular contours performed in a healthy control using reference ranges from
Maceira et al7 and Petersen et al.4 The panels demonstrate contouring of the ventricles using identical SSFP cine short axis images,
from base to apex at end-diastole and end-systole, below which are tables of the respective LV parameters. For detailed contouring,
those papillary muscles and trabeculations continuous with the LV endocardial border were included in mass and excluded from the
blood pool. Note not only the differences in values, but also the different classiﬁcation of LV hypertrophy based on the two
techniques.
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time constraints, access to software with "thresholding" capability (ie,
intensity-based segmentation), availability of vendor-speciﬁc reference
ranges without information detailing papillary muscle inclusion/exclu-
sion, or failure to read and understand the reference methods. It could
also reﬂect the lack of a representative example of the contouring
method in the reference article; most,3–6 but not all,7,8 published ref-
erence ranges include exemplar ﬁgures, which should be obligatory for
any future reference technique publication.
We have performed volumetric and mass analyses in 20 consec-
utive patients (57  16 years; male 70%) with hypertrophic cardio-
myopathy (HCM), using the two most common postprocessing
methodologies based on our survey data (Table 2).4,7 HCM was
deﬁned by the presence of LV wall thickness ≥ 15 mm unexplained
by loading conditions. Nine patients (45%) with a supranormal LV
ejection fraction by detailed contours were reclassiﬁed with a normal
ejection fraction by smoothed contours. Four patients (20%) with LV
hypertrophy according to detailed contours had a normal indexed LV
mass by smoothed contours. These data suggest using smoothed con-
tours is untenable in HCM and its phenocopies—the presence of
large papillary muscles and extensive trabeculations leads to inaccu-
racy, often missing hyperdynamic function.9,10 Additionally, when
serial imaging is requested to characterize the clinical course of HCM,
variable contouring practice between centers will result in reported dif-
ferences in LV parameters that has the potential to mislead clinicians.
Inconsistent conclusions arising from analyses using these two
distinct contouring techniques are not restricted to patients with
overt pathology. In Fig. 1, we provide examples of myocardial con-
tours in a healthy 52-year-old Caucasian female (without prior cardio-
vascular disease and with a normal 24-hour ambulatory blood
pressure). Again, there are important differences in the values obtained
for LV parameters dependent on the contouring method. A more
striking ﬁnding, however, is the difference between the two reference
datasets in the normal cutoff value for LV mass. This healthy control
subject is classiﬁed abnormal with eccentric LV hypertrophy according
to the UK Biobank dataset,4 while LV mass is well within the normal
range using methods described by Maceira et al.7
The exclusion of non-Caucasians and subjects aged < 45 years
further limits the applicability of the UK Biobank normal range
dataset.4 The authors’ consensus opinion is that papillary muscles
are myocardial tissue and to improve accuracy (closeness of a mea-
sured value to a true value) should routinely be excluded from blood
volumes and included in LV mass. Most centers currently use soft-
ware capable of producing contours using thresholding, which
enables observers to perform detailed contouring that takes account
of papillary muscles without sacriﬁcing time.
The wide variation in cardiac MRI reporting practice empha-
sized by this survey reﬂects a global issue. Although machine learn-
ing holds promise (removing interobserver error, increasing
standardization, and permitting reference range changes "on the ﬂy"
as models reﬁne), its arrival into the clinical arena is not anticipated
for some years. There is, therefore, a pressing need to formalize the
choice of postprocessing methodology and specify a normal reference
range that the MRI community should follow.
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